Posts Feed
Comments Feed

FDA Panel Weighs Guidelines For Human Clinical Trials Involving Treatments From Embryonic Stem Cells

Because of the potential risks involved in human embryonic stem cells, data on the effectiveness of treatments using them “may need to be particularly strong,” Steven Bauer, chief of FDA’s cell and tissue therapy branch, said in a presentation to the FDA advisory

More: continued here

No Comments »

Trackback URI | Comments RSS

Leave a Reply

You must be logged in to post a comment.

1